Carey Danis & Lowe | Attorneys at Law
  • Home
  • Our Attorneys
    • About Carey Danis & Lowe
  • Featured Cases
  • Practice Areas
    • Antitrust
    • Class Actions
      • AT&T Cell Phone Bill Cramming
      • AT&T Telephone Bill Cramming
      • Credit Card Payment Protection
    • Defective & Faulty Medical Device Litigation
      • Guidant Defibrillator
      • Hip & Knee Replacement
      • Ob Tape & Slings
      • Transvaginal Mesh
    • Medical Malpractice
    • Personal Injury
      • Truck & Car Accidents
    • Pharmaceutical Litigation
      • Accutane®
      • Actos®
      • Asbestos Mesothelioma
      • Avandia®
      • Celexa®
      • Levaquin®
      • Lexapro®
      • Luvox®
      • Mirena®
      • NuvaRing®
      • Paxil®
      • Pradaxa®
      • Prozac®
      • Symbyax®
      • Topamax®
      • Wellbutrin®
      • Yaz® Yasmin®
      • Zoloft®
    • Product Liability
    • Securities Fraud
    • Unfair & Deceptive Trades
  • Firm News
    • Firm Resume
    • Press Release
    • Testimonials
  • Contact Us
    • via Email
    • via Facebook
    • via LinkedIn
    • via Twitter
    • via RSS
  • Blog
Like Carey Danis & Lowe on FacebookConnect With Carey Danis & Lowe on LinkedInFollow Carey Danis & Lowe on TwitterSubscribe to Carey Danis & Lowe via RSS

  P.  800.721.2519
 Ask a Nurse

DePuy ASR Hip Replacement Trial Scheduled to Begin on January 22, 2013 in California Superior Court

Submit Your Claim Information from a Johnson & Johnson internal study into the safety of the DePuy ASR Hip Replacement system is suggestive that the medical device manufacturer understood the serious risks associated with their hip implant. The Johnson & Johnson internal study was recently unsealed in pretrial proceedings in a DePuy ASR Hip Replacement lawsuit in California, overseen by Judge J. Stephen Czuleger. As detailed in the internal study document, the DePuy hip implant proved defective, having a significantly high failure rate with approximately 40% of patients experiencing Continue Reading

FDA Releases Safety Communication about Metal-On-Metal Hip Implants: New Safety Communication Warns About High Failure Rates and Metal Ion Reactions

Submit Your Claim The U.S. Food & Drug Administration (FDA) issued an updated safety communication regarding metal-on-metal hip implants on January 17, 2013. The safety communication reports how metal-on-metal hip replacement systems by design have early and high failure rates. Furthermore, as a result of the hip replacement components making contact with one another during movement like walking or running, metal particles are released into the patient’s body and bloodstream, which may result in what the FDA calls adverse local tissue reactions (ALTR). As detailed in the FDA’s safety Continue Reading

DePuy ASR Hip Replacement Lawsuit Update: Trials Scheduled to Begin this Year in Maryland, New Jersey, and Ohio

Submit Your Claim Around the country, individuals have been filing DePuy ASR Hip Replacement lawsuits, and a handful of these suits are slated to begin trial later this year. DePuy ASR Hip Replacement cases are pending in Ohio, Maryland, California, and New Jersey. One trial being heard in Maryland was scheduled to begin on January 7, 2013, but court proceedings have since been stopped as the plaintiff considers consolidating the case into a federal court in Ohio. The case is Jackson v. DePuy Orthopaedics Inc., which up until the Continue Reading

First Trials for Defective DePuy ASR Hip Replacement System Set for January 2013

Submit Your Claim A state case regarding the recalled DePuy ASR hip replacement system is scheduled to go to trial in January 2013 in Prince George’s County, Maryland. If DePuy does not settle with plaintiffs before trials begin, the Maryland court will hear three cases regarding health complications related to DePuy’s ASR hip implants. In August 2012, DePuy, a subsidiary of Johnson & Johnson, settled state cases in Nevada regarding defective ASR hip replacement lawsuits. Trials for these ASR hip replacement cases filed against DePuy were scheduled to begin Continue Reading

Stryker Recalls Rejuvenate and ABG II Modular Hip Replacement Systems

In July 2012, Stryker issued a press release with information about a voluntary recall of its Rejuvenate modular-neck stems and its ABG II modular-neck stems, both of which are hip replacement systems manufactured and marketed by Stryker. The medical device manufacturer made the decision to voluntarily recall the Rejuvenate and ABG II hip replacement systems due to reports of fretting and corrosion as well as severe inflammation of adjacent tissues. In the Stryker recall press release, Stuart Simpson, Stryker’s Vice President and General Manager, Hip Reconstruction, states that, “given Continue Reading

Zimmer Issued Warning from FDA Regarding Hip Replacement System

In a letter from the U.S. Food and Drug Administration (FDA) dated September 19, 2012, Zimmer Holdings Inc. was issued a warning regarding their hip replacement device known as the Trilogy Acetabular System. The letter of warning followed a recent FDA inspection of a Zimmer Holdings Inc. plant located in Puerto Rico. The FDA observed while at Zimmer’s Puerto Rican plant that the medical device manufacturer had not established proper testing methods for the hip replacement device. The FDA requires that measures for testing be pursued in order to Continue Reading

DePuy Hip Replacements Require Revision Surgery

In 2010, DePuy recalled two types of hip replacements, the ASR XL Acetabular System and the ASR Hip Resurfacing System. DePuy Orthopaedics is a subsidiary of Johnson & Johnson. DePuy decided to recall two types of hip replacements due to patients needing a second hip replacement after an unsuccessful first implant. According to complaints filed with the U.S. Food and Drug Administration (FDA), these two kinds of DePuy hip replacements have been known to fail soon after surgery, and quite often, have caused excruciating pain requiring another hip replacement Continue Reading

Metal-on-Metal Hip Replacements Corrode Faster

Published May 13, 2012 by LawsuitInformation.org Can the fact that metal on metal hips may corrode faster than hips made from traditional materials, be the casue of their early failure? According to new medical research, metal-on-metal hip replacements may corrode faster than traditional types of artificial hip implants, such as those made from plastic or ceramic. Experts speculate that the corrosion may be linked to an increased risk of local tissue reactions that require revision or removal of the artificial hip implant. Researchers examined corrosion on the heads of Continue Reading

New Lawsuit on DePuy ASR Hip Replacement: Severe Adverse Events

Published May 14, 2012 on LawsuitInformation.org According to court documents, on May 7th 2012, a Virginia woman, Abbdella Brown, filed a lawsuit in Ohio Northern District Court (case no. 1:2012dp21074) against DePuy Orthopaedics alleging she suffered serious injuries due to ASR Hip Implant Device. DePuy Orthopeadics, a subsidiary of Johnson & Johnson, is defending lawsuits in multidistrict litigations alleging that its ASR hip replacement (MDL 2197) and the metal-on-metal Pinnacle hip replacement systems (MDL 2244) were defectively designed. In August 2010, the DePuy ASR hips were recalled. San Diego, Continue Reading

New Lawsuit on Zimmer Durom Cup: Adverse Events

Published May 17, 2012 on LawsuitInformation.org According to court documents, on March 15th, 2012, a California resident, Therese Gonzales, filed a lawsuit in New Jersey District Court (case no. 2:2012cv01651) against Zimmer Inc. alleging that Zimmer Durom Cup was defectively designed and caused her pain and side effects that “are consistent with loosening of the acetabular cups used in her hip replacements”. The Zimmer Durom Cup is an artificial hip component widely used in hip replacement surgeries in the US since 2006. On June 9th, 2010, the US Judicial Continue Reading

Next Page »
  • Featured Cases & Current Litigation

    • Vaginal Mesh Litigation
    • Topamax® Birth Defects
    • Lexapro® & Birth Defects
    • Pradaxa® Internal Bleeding
    • Prozac® & Birth Defects
    • Yaz® & Yasmin® Blood Clots
    • Transvaginal Mesh Injury
    • Paxil® & Birth Defects
    • NuvaRing® Blood Clots
    • Mirena® IUD Complications
    • Asbestos Mesothelioma
    • Trucking Accidents & Passenger Vehicle Collision Settlements
  • Recent Posts & News Articles

    • NuvaRing Lawsuit News from Carey Danis & Lowe NuvaRing Law Firm: Seven Cases Removed from NuvaRing Multicounty Litigation in New Jersey
    • Carey Danis & Lowe Actos Lawyers Comment on Annulled Cooper v. Takeda Compensatory Award
    • Chicago DePuy Hip Trial Jury Rules in Favor of Johnson & Johnson and DePuy
    • Cooper v. Takeda Jury Presented with Plaintiff Closing Argument Linking Actos and Bladder Cancer
    • Bayer Loses Yaz Patent in Federal Court of Appeals: Generic Yaz Versions Begin (Stealing) Marketshare
    • Carey Danis & Lowe Pradaxa Lawyers Currently Following Pradaxa MDL 2385
    • FDA Approves New Anticoagulation Reversal Agent and Boehringer Ingelheim Updates Pradaxa Label
    • Carey Danis & Lowe Actos Cancer Lawyers Optimistic Following Cooper v. Takeda $6.5 Million Compensatory Award
Our Offices
Saint Louis, Missouri
8235 Forsyth Ste 1100
St. Louis, MO 63105
T. 314 725 7700
F. 314 721 0905
Godfrey, Illinois
5512 Godfrey Road
Godfrey, IL 62035
T. 618 463 0644
F. 314 721 0905
Belleville, Illinois
5111 W. Main Street
Belleville, IL 62226
T. 618 212 6300
F. 314 721 0905
Vero Beach, Florida
612 Beachland Blvd
Vero Beach, FL 32963
T. 314 725 7700
F. 314 721 0905
© 2013 Carey Danis & Lowe
reVisioned.by
Toll Free P. 800-721-2519
Home • Contact • About